These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24657288)

  • 21. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
    González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
    Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory properties of borage (Echium amoenum) on BALB/c mice infected with Leishmania major.
    Hosseini N; Abolhassani M
    J Clin Immunol; 2011 Jun; 31(3):465-71. PubMed ID: 21225450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
    Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
    Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
    Zadeh-Vakili A; Taheri T; Taslimi Y; Doustdari F; Salmanian AH; Rafati S
    Vaccine; 2004 May; 22(15-16):1930-40. PubMed ID: 15121305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of aligned hematite nanoparticles on chitosan-alginate films.
    Sreeram KJ; Nidhin M; Nair BU
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):260-7. PubMed ID: 19303261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis.
    Valadares DG; Duarte MC; Ramírez L; Chávez-Fumagalli MA; Lage PS; Martins VT; Costa LE; Ribeiro TG; Régis WC; Soto M; Fernandes AP; Tavares CA; Coelho EA
    Parasitol Res; 2012 Oct; 111(4):1807-16. PubMed ID: 22797606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
    Webb JR; Kaufmann D; Campos-Neto A; Reed SG
    J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL/6 mice.
    Doroud D; Zahedifard F; Vatanara A; Najafabadi AR; Rafati S
    Parasite Immunol; 2011 Jun; 33(6):335-48. PubMed ID: 21410716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis.
    Tafaghodi M; Eskandari M; Khamesipour A; Jaafari MR
    Exp Parasitol; 2011 Oct; 129(2):107-14. PubMed ID: 21767536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    Nanomedicine; 2007 Sep; 3(3):239-43. PubMed ID: 17652032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of liposome-protamine-DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice.
    Alavizadeh SH; Badiee A; Khamesipour A; Jalali SA; Firouzmand H; Abbasi A; Jaafari MR
    Exp Parasitol; 2012 Nov; 132(3):313-9. PubMed ID: 22819791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis.
    Evans TG; Thai L; Granger DL; Hibbs JB
    J Immunol; 1993 Jul; 151(2):907-15. PubMed ID: 8335918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.
    Nagarwal RC; Kumar R; Pandit JK
    Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatment.
    Carter KC; Gallagher G; Baillie AJ; Alexander J
    Eur J Immunol; 1989 Apr; 19(4):779-82. PubMed ID: 2786473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles.
    Douglas KL; Piccirillo CA; Tabrizian M
    J Control Release; 2006 Oct; 115(3):354-61. PubMed ID: 17045691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis.
    Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA
    Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.
    Borges O; Tavares J; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):278-90. PubMed ID: 17884394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.